Literature DB >> 36198786

Using proteins to test for COVID antibodies.

Helen Santoro.   

Abstract

Entities:  

Keywords:  Diseases; Health care; Proteomics

Mesh：

Substances：

Year:  2022        PMID： 36198786     DOI： 10.1038/d41586-022-03137-1

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   69.504


× No keyword cloud information.
  4 in total

1.  A high-throughput pipeline for validation of antibodies.

Authors:  Krzysztof Sikorski; Adi Mehta; Marit Inngjerdingen; Flourina Thakor; Simon Kling; Tomas Kalina; Tuula A Nyman; Maria Ekman Stensland; Wei Zhou; Gustavo A de Souza; Lars Holden; Jan Stuchly; Markus Templin; Fridtjof Lund-Johansen
Journal:  Nat Methods       Date:  2018-10-30       Impact factor: 28.547

2.  Immunogenicity and Safety of a Third SARS-CoV-2 Vaccine Dose in Patients With Multiple Sclerosis and Weak Immune Response After COVID-19 Vaccination.

Authors:  Marton König; Hilde Marie Torgauten; The Trung Tran; Trygve Holmøy; John Torgils Vaage; Fridtjof Lund-Johansen; Gro Owren Nygaard
Journal:  JAMA Neurol       Date:  2022-03-01       Impact factor: 18.302

3.  Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study.

Authors:  Ingrid Jyssum; Hassen Kared; Trung T Tran; Anne T Tveter; Sella A Provan; Joseph Sexton; Kristin K Jørgensen; Jørgen Jahnsen; Grete B Kro; David J Warren; Eline B Vaage; Tore K Kvien; Lise-Sofie H Nissen-Meyer; Ane Marie Anderson; Gunnveig Grødeland; Espen A Haavardsholm; John Torgils Vaage; Siri Mjaaland; Silje Watterdal Syversen; Fridtjof Lund-Johansen; Ludvig A Munthe; Guro Løvik Goll
Journal:  Lancet Rheumatol       Date:  2021-12-23

4.  Fourth dose of the SARS-CoV-2 vaccine in kidney transplant recipients with previously impaired humoral antibody response.

Authors:  Karsten Midtvedt; John Torgils Vaage; Kristian Heldal; Ludvig A Munthe; Fridtjof Lund-Johansen; Anders Åsberg
Journal:  Am J Transplant       Date:  2022-05-09       Impact factor: 9.369
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.